Courtney Larue
Psychiatric/Mental Health · Delray Beach, FLNPI 1194360354
Payments from drug & device makers
Across 151 payments — averaging $17.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$804
- Alkermes, Inc.$270
- Neurocrine Biosciences, Inc.$263
- Otsuka America Pharmaceutical, Inc.$242
- Indivior Inc.$210
- Idorsia Pharmaceuticals US Inc$189
- plus $616 from 12 others
What the payments were for
- Food & beverage$2,594100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 63 | $804 |
| Alkermes, Inc. | 12 | $270 |
| Neurocrine Biosciences, Inc. | 12 | $263 |
| Otsuka America Pharmaceutical, Inc. | 14 | $242 |
| Indivior Inc. | 10 | $210 |
| Idorsia Pharmaceuticals US Inc | 9 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $148 |
| Corium, LLC | 7 | $120 |
| Almatica Pharma LLC | 4 | $76 |
| Johnson & Johnson | 2 | $72 |
| Lundbeck LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Orexo US, Inc. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $19 |
| Neos Therapeutics, LP | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $14 |
How this compares
$2,594 in reported general payments places this provider in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 11 | $138,633 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 53 | $1,703 |
| Aripiprazole | 51 | $1,495 |
| Bupropion XlBupropion Hcl | 95 | $1,421 |
| Quetiapine Fumarate | 79 | $1,313 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $1,267 |
| Lorazepam | 68 | $1,041 |
| Alprazolam | 201 | $949 |
| Divalproex Sodium ErDivalproex Sodium | 20 | $859 |
| Olanzapine | 12 | $696 |
| Fluoxetine Hcl | 85 | $671 |
| Mirtazapine | 72 | $666 |
| Ziprasidone Hcl | 18 | $660 |
| Buspirone Hcl | 47 | $623 |
| Sertraline Hcl | 63 | $516 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $40 | $138,63311 claims |
| Almatica Pharma LLCSertraline Hcl | $76 | $51663 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Delray Beach
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.